| 000 | 01780 a2200529 4500 | ||
|---|---|---|---|
| 005 | 20250517135336.0 | ||
| 264 | 0 | _c20170519 | |
| 008 | 201705s 0 0 eng d | ||
| 022 | _a1526-632X | ||
| 024 | 7 |
_a10.1212/WNL.0000000000003660 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aNash, Richard A | |
| 245 | 0 | 0 |
_aHigh-dose immunosuppressive therapy and autologous HCT for relapsing-remitting MS. _h[electronic resource] |
| 260 |
_bNeurology _cFeb 2017 |
||
| 300 |
_a842-852 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aDisability Evaluation |
| 650 | 0 | 4 | _aDisease-Free Survival |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aHematopoietic Stem Cell Transplantation _xadverse effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmunosuppressive Agents _xadministration & dosage |
| 650 | 0 | 4 | _aMagnetic Resonance Imaging |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMultiple Sclerosis, Relapsing-Remitting _xdiagnostic imaging |
| 650 | 0 | 4 |
_aTransplantation, Autologous _xadverse effects |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aHutton, George J | |
| 700 | 1 | _aRacke, Michael K | |
| 700 | 1 | _aPopat, Uday | |
| 700 | 1 | _aDevine, Steven M | |
| 700 | 1 | _aSteinmiller, Kaitlyn C | |
| 700 | 1 | _aGriffith, Linda M | |
| 700 | 1 | _aMuraro, Paolo A | |
| 700 | 1 | _aOpenshaw, Harry | |
| 700 | 1 | _aSayre, Peter H | |
| 700 | 1 | _aStuve, Olaf | |
| 700 | 1 | _aArnold, Douglas L | |
| 700 | 1 | _aWener, Mark H | |
| 700 | 1 | _aGeorges, George E | |
| 700 | 1 | _aWundes, Annette | |
| 700 | 1 | _aKraft, George H | |
| 700 | 1 | _aBowen, James D | |
| 773 | 0 |
_tNeurology _gvol. 88 _gno. 9 _gp. 842-852 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1212/WNL.0000000000003660 _zAvailable from publisher's website |
| 999 |
_c26839744 _d26839744 |
||